These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22659243)

  • 1. Frontiers in preclinical safety biomarkers: microRNAs and messenger RNAs.
    Mikaelian I; Scicchitano M; Mendes O; Thomas RA; Leroy BE
    Toxicol Pathol; 2013 Jan; 41(1):18-31. PubMed ID: 22659243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic primer extension assay.
    Beier M; Boisguérin V
    Methods Mol Biol; 2012; 822():143-52. PubMed ID: 22144197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
    Weiland M; Gao XH; Zhou L; Mi QS
    RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets.
    Stakos DA; Gatsiou A; Stamatelopoulos K; Tselepis AD; Stellos K
    Platelets; 2013; 24(8):579-89. PubMed ID: 22994623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs: potential biomarkers for disease diagnosis.
    Xu L; Qi X; Duan S; Xie Y; Ren X; Chen G; Yang X; Han L; Dong Q
    Biomed Mater Eng; 2014; 24(6):3917-25. PubMed ID: 25227110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental identification of microRNA targets by immunoprecipitation of Argonaute protein complexes.
    Beitzinger M; Meister G
    Methods Mol Biol; 2011; 732():153-67. PubMed ID: 21431712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors.
    Lässer C
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S189-97. PubMed ID: 22506888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs: macro-utility as markers of prostate cancer?
    Selth LA; Tilley WD; Butler LM
    Endocr Relat Cancer; 2012 Aug; 19(4):R99-R113. PubMed ID: 22492480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MicroRNAs in diagnosis and prognosis in lung cancer].
    Avila-Moreno F; Urrea F; Ortiz-Quintero B
    Rev Invest Clin; 2011; 63(5):516-35. PubMed ID: 22468482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA expression in the eyes and their significance in relation to functions.
    Xu S
    Prog Retin Eye Res; 2009 Mar; 28(2):87-116. PubMed ID: 19071227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as biomarkers in pituitary tumors.
    Di Ieva A; Butz H; Niamah M; Rotondo F; De Rosa S; Sav A; Yousef GM; Kovacs K; Cusimano MD
    Neurosurgery; 2014 Aug; 75(2):181-9; discussion 188-9. PubMed ID: 24739366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
    Zen K; Zhang CY
    Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
    Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ
    Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs are novel biomarkers of colorectal cancer.
    Aslam MI; Taylor K; Pringle JH; Jameson JS
    Br J Surg; 2009 Jul; 96(7):702-10. PubMed ID: 19526617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing the genome: microRNAs in Drosophila.
    Gesellchen V; Boutros M
    Differentiation; 2004 Mar; 72(2-3):74-80. PubMed ID: 15066187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNAs and long noncoding RNAs as biomarkers in human diseases.
    Van Roosbroeck K; Pollet J; Calin GA
    Expert Rev Mol Diagn; 2013 Mar; 13(2):183-204. PubMed ID: 23477558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in the use of microRNAs as biomarkers for drug-induced toxicities in contrast to traditional biomarkers: A comparative review.
    Oda S; Yokoi T
    Drug Metab Pharmacokinet; 2021 Apr; 37():100372. PubMed ID: 33461055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances of utilizing microRNAs as biomarkers].
    Qiao J; Jin R
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2202-5. PubMed ID: 23189718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing sample and miRNA profile quality in serum and plasma or other biofluids.
    Blondal T; Jensby Nielsen S; Baker A; Andreasen D; Mouritzen P; Wrang Teilum M; Dahlsveen IK
    Methods; 2013 Jan; 59(1):S1-6. PubMed ID: 23036329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of miRNA in carcinogenesis and biomarker selection: a methodological view.
    Ahmed FE
    Expert Rev Mol Diagn; 2007 Sep; 7(5):569-603. PubMed ID: 17892365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.